A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：ORGANIC PROCESS RESEARCH & DEVELOPMENT ISSN： 1083-6160 出版频率： Bi-monthly 出版社： AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, USA, DC, 20036   出版社网址： http://pubs.acs.org/ 期刊网址： http://pubs.acs.org/journal/oprdfk 影响因子： 3.317 主题范畴： CHEMISTRY, APPLIED;    CHEMISTRY, ORGANIC 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Organic Process Research & Development reports work in the broad field of process chemistry encompassing aspects of organic chemistry, catalysis, analytical chemistry, and chemical engineering. There is special focus on the development and optimization of chemical reactions and processes and their transfer to a larger scale, via large laboratory and pilot plant operations, for manufacturers. The journal covers research and development in the fine organic chemicals and specialty chemicals industries, including pharmaceuticals, agrochemicals, dyestuff and photographic chemicals, flavors and fragrances, electronics, intermediates, food additives, and specialty polymers, and academic chemistry related to work in these industries.   Instructions to Authors Authors are encouraged to use the Organic Process Research & Development Document Templates for preparing manuscripts for submission as well as for preparing final, accepted manuscripts. Scope of the Journal (PDF) Guidelines for Authors (PDF) Permission Request Guidelines to Use Material from the ACS Publications Division Instructions on Reference Citations Avoid unnecessarily long reference lists by selecting citations judiciously and citing reviews when possible. Literature citations and explanatory notes must be numbered in one consecutive series by order of mention in the text, with the numbers presented as unparenthesized superscripts. The following are examples of the appropriate style for use in citations. For journals Laird, T. Spec. Chem. 1992, 12, 324. For books Lipton, S.; Lynch, J. Handbook of Health Hazard Control in the Chemical Process Industry; Wiley: New York, 1994. In literature references, journal abbreviations should be those used by Chemical Abstracts [see Chemical Abstracts Service Source Index (CASSI) 1907-1999 Cumulative]. Experience has shown that a high percentage of references contain errors (e.g., misspelled or omitted author names or incorrect volume number, page number, or year). In no case should citations be copied from another source without checking the original reference for accuracy and appropriate content. Because subscribers to the Web edition of the journal are now able to click on the "CAS" tag following each reference to retrieve the corresponding abstract at Chemical Abstracts Service, reference accuracy is critical. Download the list of standard abbreviations as a reference for the preparation of your manuscript. Preparation and Submission of Hardcopy Manuscripts Author instructions vary somewhat for each journal. However, there are general instructions for all journals that include the following: How to Submit Online Preferred Software Preparing Manuscripts Using TeX/LaTeX Preparing Graphics and Illustrations Submitting a Hardcopy Manuscript Completing a Diskette Description Form (PDF) The complete set of copyright forms used by ACS journals can be found here. Additional information on Organic Process Research & Development can be found at the journal Home Page.   Instructions to Authors 1083-6160.pdf Editorial Board   EDITOR ASSOCIATE EDITOR Trevor Laird Scientific Update LLP Maycroft Place, Stone Cross Mayfield, East Sussex TN20 6EW, UK Christopher Schmid Chemical Process Research and Development Lilly Research Laboratories Eli Lilly and Company Indianapolis, IN 46285-4813 EDITORIAL BOARD Michael Bech Sommer Lundbeck A/S, Denmark Tamim F. Braish Pfizer Global R&D, USA Jos Brands Merck, Sharp & Dohme, U.K. Alle Bruggink DSM Research, The Netherlands Mukund Chorghade Chorgrade Enterprises, USA Christophe Daubie Aventis Pharmaceuticals, France Fons De Knaep Johnson & Johnson PRD, Belgium Kumar Gadamasetti X-Mine, Inc., USA Dinesh Gala Schering Plough Research, Inst., USA Christian T. Goralski The Dow Chemical Company, USA Jai S. Goudar FMC Corporation, USA Mukund Gurjar National Chemical Laboratory, India David Haywood AstraZeneca R&D, U.K. Robert Hett CarboGen Laboratories AG, Switzerland Marvin Hoekstra Pfizer Global R&D, USA Raghaven Krishnan Wyeth-Ayerst Laboratories, USA Naresh Kumar Ranbaxy Laboratories, India David Lathbury AstraZeneca, U.K. Ian Lennon The Dow Chemical Company, U.K David Lathbury AstraZeneca, U.K. Ian Lennon The Dow Chemical Company, U.K. Steve Ley University of Cambridge, U.K. Michael F. Lipton Pharmacia, USA Mahmoud Mahmoudian GlaxoSmithKline, U.K. Ching-Pong Mak Novartis Pharma AG, Switzerland Noritada Matsuo Sumitomo Chemical Co. Ltd., Japan Harold Meckler Albany Molecular Research, USA Howard Morton Abbot Laboratories, USA Richard Mueller Bristol-Myers Squibb, USA Ram Narayan Roche Pharmaceuticals, USA Richard Pariza CP Consulting, USA Terry L. Rathman t-Links, USA Dennis P. Riley Metaphore Pharmaceutical Inc., USA Carlos B. Rosas Consultant, USA Tino Rossi GlaxoSmithKline Medical Research, Italy Yogesh S. Sanghvi ISIS Pharmaceuticals, USA Bernard Scholl Roche Pharmaceuticals Ltd., Switzerland Eric Scriven Reilly Industries, Inc., USA Chris H. Senanayake Boehringer Ingelheim Pharmaceuticals, USA Barry Sharpless The Scripps Research Institute, USA Roger Sheldon Delft Univ. of Technology, The Netherlands Ichiro Shinkai Mitsui & Co. Ltd., Japan Victor Snieckus Queens University, Canada John R. J. Surtees UCB Pharma, Belgium Ulf Tilstam Schering AG, Germany Jo Ann Wilson Ligand Pahrmaceuticals, USA Atsuhiko Zanka Fujisawa Pharmaceutical Co. Ltd., Japan